Sundar Pichai, CEO of Google

At five past eight on a Monday morning, a patient in a Midlands surgery pushes up a sleeve and shows the GP a graph. It records three weeks of drift in an estimated blood pressure, with a note that an insulin resistance trend has also shifted. The GP has ten minutes, no local protocol for this conversation and a waiting room already full. The device on the wrist cost about $180.

That device is the Fitbit Edge, which Google is rolling out from late October. Its Health Guardian features track blood pressure and insulin resistance trends in the background, and a paid coaching tier offers to give users context for conversations with their doctor. Whatever the marketing intends, the product is designed to generate appointments.

The relevance to the NHS is structural, and it begins with how the system defines disease. Care is organised around thresholds, confirmed by clinic or home readings taken with a validated cuff. A wrist-worn estimate of a trend sits awkwardly beside that model. Cuffless blood pressure estimation remains contested in clinical research, and UK guidance still rests on conventional measurement. A wearable alert is therefore a prompt for a proper reading rather than a diagnosis, and the system has few ways to say so at scale.

There is a genuine upside. Millions of adults in the UK are thought to live with undiagnosed hypertension, and the NHS has spent years trying to find them through pharmacy checks and home monitoring schemes. A device that nudges someone towards a cuff measurement could reach people the existing programmes miss. The same device could send the worried well into general practice in numbers that outstrip any benefit. Even a modest false alert rate, multiplied across a large user base, becomes a significant volume of consultations in a service already struggling with access and productivity.

Regulation shapes which outcome materialises. Software with a medical purpose falls within the remit of the Medicines and Healthcare products Regulatory Agency, and the line between a wellness feature and a regulated device depends largely on the claims a manufacturer makes. How the Edge's trend features will be positioned for British buyers is not yet clear, and the answer matters. A product marketed as lifestyle guidance carries lighter obligations than one that implies detection of a condition, yet the patient experience is the same.

Government ambition adds a further layer. The ten year health plan for England promises a more personalised NHS App and a greater role for remote monitoring and patient-held data. Ministers want citizens to generate and share health information. They have said less about what clinicians should do when that information arrives from a commercial platform with its own algorithms and a subscription model. Questions of consent and custody follow. Health data held by a large technology company, enriched by a paid coaching service, sits outside the single patient record the NHS wants to build. The 2017 finding by the Information Commissioner against an NHS trust over data shared with a Google subsidiary still frames public attitudes, and trust is easier to lose than to rebuild.

Practical steps are available. NHS England and integrated care boards could issue short guidance for primary care on consumer device data, setting out what triggers a confirmatory measurement and which part of the system performs it. Pharmacies and home monitoring schemes are better placed than GP surgeries to absorb the first wave. The regulator should state plainly how it will treat trend features that stop short of diagnosis. Health-tech firms able to show validated accuracy and a route into NHS records will hold an advantage over those that cannot. Patients, meanwhile, are best advised to treat a wrist alert as a reason to take a cuff reading and nothing more.

One watch will not change the health service. The sensible expectation is that the first patient with the graph arrives well before the guidance does, and the quality of that consultation will say a good deal about how ready the state is for the data it has asked citizens to collect.

‍